SELLAS Life Sciences Group Inc. (SLS)

1.7 +0.04 (+2.41%)

IEX Real-Time Price

July 16, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 1.66

Price Open 1.74

Volume: 561,000

Avg Volume: 437,325

Market Cap: 11.31M

P/E Ratio -0.18

52 Wk Range 1.6-17.7



SLS Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-06-15
4.6M
499,580
1.58
10.86%

2018-05-31
4.6M
271,077
4.76
5.89%

2018-05-15
4.6M
332,413
3.66
7.23%

2018-04-30
4.53M
276,768
0.18
6.11%




SLS Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-07-04
Q1 2018
N/A
0.00 (1)
0.00
0.00

2018-06-20
Q1 2018
N/A
-0.93 (1)
0.00
0.00

2018-05-09
Q1 2018
N/A
-0.93 (1)
0.00
0.00

2018-04-04
Q4 2017
N/A
0.00 (0)
0.00
0.00

News

Midday Gainers / Losers (07/12/2018) (2018-07-12 12:44 SeekingAlpha)

Gainers: CNTF +70% . GLMD +26% . FPI +23% . AMBO +22% . PBSK +21% . OPNT +18% . CA +18% . ZGNX +18% . JAGX +17% . BLFS +14% . More news on: China TechFaith Wireless Communication Technology Limited, Galmed Pharmaceuticals Ltd., Farmland Partners Inc, Stocks…

 

SELLAS prices upsized equity offering; shares down 25% premarket (2018-07-12 09:23 SeekingAlpha)

SELLAS Life Sciences Group (NASDAQ: SLS ) has priced its public offering of 11.52M shares of common stock and pre-funded warrants at a combined price of $2.10. More news on: SELLAS Life Sciences Group, Inc., Healthcare stocks news, Stocks on the move, Read more …

 

Premarket Losers as of 9:05 am (07/12/2018) (2018-07-12 09:20 SeekingAlpha)

SSLJ -38% . More news on: SSLJ. COM LTD, SELLAS Life Sciences Group, Inc., Biocept, Inc., Stocks on the move, Read more …

 


Statistics

Shares Outstanding: 6.66M

Top 15 Institution Percent: 6.00

Price To Sales: N/A

Price To Book: 18.13

Revenue: N/A

Gross Profit: N/A

Cash: 30.99M

Debt: N/A

Return On Assets: -57.39

Return On Equity: -230.26

Profit Margin: N/A

Price History

Beta: 1.65

50-day Moving Avg: 4.78

200-day Moving Avg: 6.88

YTD Change: -75.24

5-day Change: -47.80

1-month Change: -66.05

3-month Change: -69.82

6-month Change: -78.04

1-year Change: -90.19

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: SELLAS Life Sciences Group Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: https://www.sellaslifesciences.com

SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S and NeuVax.